Quince Therapeutics, Inc. short interest in 2023
In 2023, Quince Therapeutics, Inc.'s disclosed short interest ran from 8.65% of shares outstanding on 13 Jan 2023 to 5.19% on 29 Dec 2023, a change of -3.46 percentage points. The year's high was 11.23% on 31 Jan 2023 and its low 4.48% on 15 Dec 2023, averaging 7.70% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 47.32 days on 31 Oct 2023. Full history: Quince Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 8.65% (13 Jan 2023)
- End of year
- 5.19% (29 Dec 2023)
- Change
- -3.46 pp
- High
- 11.23% (31 Jan 2023)
- Low
- 4.48% (15 Dec 2023)
- Average
- 7.70%
- Highest days to cover
- 47.32 (31 Oct 2023)
- SEC filings marked
- 6
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 8.65% | 15.99 | |
| 31 Jan 2023 | 11.23% | 1.00 | results (8-K) |
| 15 Feb 2023 | 8.63% | 8.64 | |
| 28 Feb 2023 | 8.59% | 6.78 | |
| 15 Mar 2023 | 9.59% | 15.16 | 10-K filed |
| 31 Mar 2023 | 9.96% | 1.00 | |
| 14 Apr 2023 | 8.55% | 7.73 | |
| 28 Apr 2023 | 8.91% | 12.10 | |
| 15 May 2023 | 8.33% | 32.36 | 10-Q filed |
| 31 May 2023 | 8.77% | 24.54 | |
| 15 Jun 2023 | 8.98% | 37.32 | |
| 30 Jun 2023 | 8.91% | 40.58 | |
| 14 Jul 2023 | 8.92% | 16.54 | |
| 31 Jul 2023 | 7.91% | 2.78 | results (8-K) |
| 15 Aug 2023 | 7.14% | 13.72 | 10-Q filed |
| 31 Aug 2023 | 6.67% | 17.98 | |
| 15 Sep 2023 | 6.57% | 40.76 | |
| 29 Sep 2023 | 6.43% | 12.20 | |
| 13 Oct 2023 | 6.47% | 27.53 | |
| 31 Oct 2023 | 5.95% | 47.32 | |
| 15 Nov 2023 | 5.08% | 34.59 | 10-Q filed |
| 30 Nov 2023 | 5.01% | 24.20 | |
| 15 Dec 2023 | 4.48% | 13.88 | |
| 29 Dec 2023 | 5.19% | 33.67 |
See also: Quince Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.